dcsimg PHIP
 
Wuhan YZY Biopharma Co., Ltd. - B
YOU SHOULD READ THE WARNING IN THE DOCUMENT.
 
WARNING
IMPORTANT
EXPECTED TIMETABLE
CONTENTS
SUMMARY
DEFINITIONS
GLOSSARY OF TECHNICAL TERMS
FORWARD-LOOKING STATEMENTS
RISK FACTORS
WAIVERS FROM STRICT COMPLIANCE WITH THE LISTING RULES AND EXEMPTION FROM COMPLIANCE WITH THE COMPANIES (WINDING UP AND MISCELLANEOUS PROVISIONS) ORDINANCE
INFORMATION ABOUT THIS DOCUMENT AND THE [REDACTED]
DIRECTORS, SUPERVISORS AND PARTIES INVOLVED IN THE [REDACTED]
CORPORATE INFORMATION
INDUSTRY OVERVIEW
REGULATORY OVERVIEW
HISTORY, DEVELOPMENT AND CORPORATE STRUCTURE
BUSINESS
FINANCIAL INFORMATION
DIRECTORS, SUPERVISORS AND SENIOR MANAGEMENT
SHARE CAPITAL
SUBSTANTIAL SHAREHOLDERS
FUTURE PLANS AND [REDACTED]
[REDACTED]
STRUCTURE OF THE [REDACTED]
HOW TO APPLY FOR [REDACTED]
APPENDIX I - ACCOUNTANTS' REPORT
APPENDIX II - UNAUDITED [REDACTED] FINANCIAL INFORMATION
APPENDIX III - TAXATION AND FOREIGN EXCHANGE
APPENDIX IV - SUMMARY OF PRINCIPAL LEGAL AND REGULATORY PROVISIONS
APPENDIX V - SUMMARY OF ARTICLES OF ASSOCIATION
APPENDIX VI - STATUTORY AND GENERAL INFORMATION
APPENDIX VII - DOCUMENTS DELIVERED TO THE REGISTRAR OF COMPANIES IN HONG KONG AND AVAILABLE ON DISPLAY